Fernandez, Jessel .

HRN: 17-50-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2022
CEFUROXIME 1.5GM (VIAL)
12/29/2022
12/31/2022
IV
1.5
Q8
LTCS
Waiting Final Action 
12/29/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/29/2022
12/31/2022
IV
500
Q8
LTCS
Waiting Final Action 
12/30/2022
CEFUROXIME 500MG (TAB)
12/30/2022
01/05/2023
PO
500mg
BID
S/p LTCS
Waiting Final Action 
12/30/2022
METRONIDAZOLE 500MG (TAB)
12/30/2022
01/05/2023
PO
500mg
TID
SP LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: